SE196140C1 - - Google Patents
Info
- Publication number
- SE196140C1 SE196140C1 SE196140DA SE196140C1 SE 196140 C1 SE196140 C1 SE 196140C1 SE 196140D A SE196140D A SE 196140DA SE 196140 C1 SE196140 C1 SE 196140C1
- Authority
- SE
- Sweden
- Prior art keywords
- acid
- thiazole
- methyl
- reacted
- thiazoles
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims description 4
- 150000003460 sulfonic acids Chemical class 0.000 claims description 3
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 claims description 2
- 229940045996 isethionic acid Drugs 0.000 claims description 2
- OPUAWDUYWRUIIL-UHFFFAOYSA-N methanedisulfonic acid Chemical compound OS(=O)(=O)CS(O)(=O)=O OPUAWDUYWRUIIL-UHFFFAOYSA-N 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- -1 aliphatic alcohols Chemical class 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 2
- AFAXGSQYZLGZPG-UHFFFAOYSA-L ethane-1,2-disulfonate Chemical compound [O-]S(=O)(=O)CCS([O-])(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-L 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 150000003557 thiazoles Chemical class 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical class [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- PCLITLDOTJTVDJ-UHFFFAOYSA-N Chlormethiazole Chemical compound CC=1N=CSC=1CCCl PCLITLDOTJTVDJ-UHFFFAOYSA-N 0.000 description 1
- 241001539473 Euphoria Species 0.000 description 1
- 206010015535 Euphoric mood Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- DSGUSEBCDAKBCM-UHFFFAOYSA-N ethane-1,2-disulfonic acid;dihydrate Chemical compound O.O.OS(=O)(=O)CCS(O)(=O)=O DSGUSEBCDAKBCM-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- OPUAWDUYWRUIIL-UHFFFAOYSA-L methanedisulfonate Chemical compound [O-]S(=O)(=O)CS([O-])(=O)=O OPUAWDUYWRUIIL-UHFFFAOYSA-L 0.000 description 1
- LLKWEEDJFSNIAI-UHFFFAOYSA-N methanedisulfonic acid;dihydrate Chemical compound O.O.OS(=O)(=O)CS(O)(=O)=O LLKWEEDJFSNIAI-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE196140T |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE196140C1 true SE196140C1 (fr) | 1964-01-01 |
Family
ID=41981684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE196140D SE196140C1 (fr) |
Country Status (1)
| Country | Link |
|---|---|
| SE (1) | SE196140C1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990009174A1 (fr) * | 1989-02-17 | 1990-08-23 | Aktiebolaget Astra | Utilisation de chlormethiazole dans la prevention et/ou le traitement de neurodegenerescences |
-
0
- SE SE196140D patent/SE196140C1/sv unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990009174A1 (fr) * | 1989-02-17 | 1990-08-23 | Aktiebolaget Astra | Utilisation de chlormethiazole dans la prevention et/ou le traitement de neurodegenerescences |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH03236318A (ja) | 抗うつ剤 | |
| BRPI0807319B1 (pt) | Base de minociclina cristalina forma 1, processo para preparar base de minociclina cristalina forma i, base de minociclina cristalina forma ii, processo para preparar base de minociclina cristalina forma ii, base de minociclina cristalina forma iii e processo para preparar base de minociclina cristalina forma iii | |
| WO2000020420A1 (fr) | Derives de mononitrate d'isosorbide et leur utilisation en tant qu'agents vasodilatateurs a tolerance reduite | |
| PT93488B (pt) | Processo de preparacao de composicoes farmaceuticas a base de (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona e destes compostos numa forma pura e cristalina | |
| SE196140C1 (fr) | ||
| GB1107470A (en) | Basic esters and a process for their production | |
| WO2020143740A1 (fr) | Molécule de promédicament dinucléotidique cyclique, son procédé de préparation et son utilisation | |
| PT98215B (pt) | Processo para a preparacao de citrato de 2-hidroxi-1,2,3-propanotricarboxilato de 3-{(5-metil-2-furanil)metil}-n-(4-piperidinil)-3h-imidazo-{4,5-b}piridin-2-amina e de composicoes farmaceuticas que o contem | |
| US3855263A (en) | Tetrahydro-2-naphthyl ester derivatives of tinonocarbanilic acids | |
| JP2512311B2 (ja) | 新規なグリセリン誘導体及び血圧降下剤 | |
| EP0124379B1 (fr) | Dérivés d'hydroquinone et procédé pour leur production | |
| US2117260A (en) | Substituted p-amino-benzene-sulphonamides and process of producting them | |
| US3031457A (en) | Salts of 4-methyl-5 (beta-halogenoethyl)-thiazole and certain sulfonic acids | |
| Biere et al. | Blood glucose lowering sulfonamides with asymmetric carbon atoms. 2 | |
| US3227718A (en) | Novel anthelminttc agents and process for producing the same | |
| US2720481A (en) | Bisulfite addition products of aldehyde derivatives of cortisone and hydrocortisone | |
| US2908694A (en) | 7-substituted thio-4-androstenes | |
| US2596631A (en) | Acylated amino acid silver salts | |
| JPH02191271A (ja) | １，５―ベンゾオキサチエピン誘導体 | |
| US2915433A (en) | 16-methylene-17beta-(alpha, beta-oxido-propanoyl)-androstenes | |
| CA3034535C (fr) | Nouveau sel de (r)- (1-methylpyrrolidin-3-yl) methyl (3'-chloro -4'-fluoro- [1,1'-biphenyl]-2-yl) carbamate et forme cristalline de celui-ci | |
| NO127154B (fr) | ||
| US2837513A (en) | Penicillin salts | |
| CA1174978A (fr) | Xanthates | |
| US3040030A (en) | New quinone derivatives and process for preparing same |